Product Information
ERYTHROMYCIN DR 333 MG TABLET is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $3.5039 per EA under NDC 13668058730. Its NADAC has been published 86 times since Nov 6, 2024.
Strength
333 mg/1
Manufacturer
Torrent Pharmaceuticals LimitedNDC
13668058730
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA211975On Market Since
10/21/2024
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN DR 333 MG TABLET has been published 86 times since Nov 6, 2024, and over the history we have for it it has risen 32.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5039 per EA |
|---|---|
| All-time high | $3.9058 (Dec 11, 2024) |
| All-time low | $2.6517 (Nov 6, 2024) |
| 52-week high | $3.7275 |
| 52-week low | $3.3321 |
| Median price | $3.5701 |
| Average price | $3.5666 |
| Largest weekly change | +47.3% (Nov 20, 2024) |
| Weeks tracked | 86 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ERYTHROMYCIN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN DR 333 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 333 MG TABLET, manufactured by Torrent Pharmaceuticals Limited, is $3.5039 per EA (NDC 13668058730), effective Jun 24, 2026.
How has the price of ERYTHROMYCIN DR 333 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN DR 333 MG TABLET has risen 32.1%. It has been tracked across 86 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 333 MG TABLET?
Since Nov 6, 2024, the NADAC for ERYTHROMYCIN DR 333 MG TABLET has ranged from a low of $2.6517 (Nov 6, 2024) to a high of $3.9058 (Dec 11, 2024), with a median of $3.5701 per EA.
Are there cheaper alternatives to ERYTHROMYCIN DR 333 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ERYTHROMYCIN DR 333 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ERYTHROMYCIN DR 333 MG TABLET?
ERYTHROMYCIN DR 333 MG TABLET (NDC 13668058730) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification